B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CHRM4

MOLECULAR TARGET

cholinergic receptor muscarinic 4

UniProt: P08173NCBI Gene: 113244 compounds

CHRM4 (cholinergic receptor muscarinic 4) is targeted by 44 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CHRM4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Hyoscyamine3.6939
2Arecoline3.6136
3Pilocarpine2.7715
4N-Methylscopolamine2.4010
5Muscarine1.956
6Scopolamine1.795
7hexahydrosiladiphenidol1.393
8Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent1.102
9Diphenhydramine1.102
10Hyoscyamine1.102
11Loxapine1.102
12Nortriptyline1.102
13Promazine1.102
14Propantheline1.102
15Strychnine1.102
16triflupromazine hydrochloride1.102
17Quetiapine Fumarate0.691
18vinpocetine0.691
19Bisphenol A-Glycidyl Methacrylate0.691
20Butaclamol0.691
21Butylscopolammonium Bromide Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of0.691
22Cefotetan0.691
23chlorprothixene hydrochloride0.691
24cinoxacin0.691
25clofilium tosylate0.691
26Cyclizine0.691
27Cyproheptadine0.691
28Desoxycorticosterone Acetate0.691
29Doxazosin0.691
30Ethylenethiourea0.691
31Maprotiline0.691
32Medroxyprogesterone0.691
33mg6240.691
34Nicardipine0.691
35Nicorandil0.691
36Perphenazine0.691
37Podophyllotoxin0.691
38Promethazine0.691
39propionylpromazine hydrochloride0.691
40Ranolazine0.691
41Thioridazine0.691
42Tilorone0.691
43Triamcinolone Acetonide0.691
44Vincamine0.691

About CHRM4 as a Drug Target

CHRM4 (cholinergic receptor muscarinic 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 44 compounds with documented CHRM4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CHRM4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.